JPRN-UMIN000003769已完成1 期
A phase I study of chemoradiotherapy (cisplatin and vinorelbine) with use of involved-field conformal radiotherapy and accelerated hyperfractionation for stage III non-small cell lung cancer - A phase I study of chemoradiotherapy with 3DCRT for stage III NSCLC
Osaka Lung Cancer Study Group0 个研究点目标入组 12 人开始时间: 2010年6月21日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) With interstitial pneuminia or pulmonary fibrosis (2) Presence of other active malignancy (3) Pregnancy or lactating patients (4) A male without the intention to contraception (5) With sever cardiac diseases (6) Un-controlled DM (7) With sever infection (8) With high fiver (9) Previous treatment of thoracic irradiation (10) Others
研究者
相似试验
已完成
1 期
A phase I study of chemoradiotherapy with use of involved-field conformal radiotherapy and accelerated hyperfractionation for stage III non-small cell lung canceron-small-cell lung cancerJPRN-UMIN000001234West Japan Oncology Group24
已完成
1 期
Phase I Study of definitive chemoradiotherapy with Docetaxel, CDDP and 5-FU for Unresectable or Recurrent Esophageal Canceradvanced or recurrence esophageal carcinomaJPRN-UMIN000003634Department of Surgery, Graduate School of Medicine, Osaka University18
已完成
2 期
A phase II study of chemoradiotherapy with use of involved-field conformal radiotherapy and accelerated hyperfractionation for Stage III non-small cell lung cancerStage III non-small cell lung cancerJPRN-UMIN000010428West Japan Oncology Group44
尚未招募
1 期
Phase I study of definitive chemoradiotherapy with paclitaxel, CDDP and 5-FU (PCF-RT) for clinical stage IA-IIIC esophageal canceresophageal cancerJPRN-UMIN000028589Osaka international cancer institute24
招募中
1 期
Phase I study of definitive CRT with paclitaxel, CDDP and 5-FU for clinical stage IA-IIIC esophageal cancer.(PCF-RT)Esophageal cancerJPRN-jRCTs051180082Yamamoto Sachiko24